National Institutes of HealthClinical Center · IEEE published 1999
"Over 50% cumulative reduction of pain and symptoms in 272 hospitalised patients."
Dr. George Patrick, chief of recreation therapy at the NIH Clinical Center, studied vibroacoustic music sessions with 272 patients — cancer, cardiac, infectious disease, mood disorders. A single 22-minute session on a vibroacoustic surface produced a cumulative pain and symptom reduction of 53%. Side effects like tension, fatigue, and nausea also dropped. This remains one of the largest vibroacoustic studies conducted.
Read on IEEE Xplore →
University of Toronto · Mt Sinai HospitalPeer-reviewed · Pain Research & Management 2015
"A quarter of fibromyalgia patients were off all pain medication after 10 sessions."
Researchers at the University of Toronto and the Wasser Pain Management Centre at Mt Sinai Hospital treated 19 fibromyalgia patients with 23 minutes of 40 Hz vibration, twice weekly for five weeks. After 10 sessions, 25% were off all pain medication entirely. The group showed significant improvement in quality of life, sleep, depression, neck and shoulder mobility, and ability to stand and sit longer.
Read the peer-reviewed paper →
Palacký University · Frontiers in PsychologyPilot RCT · 2022
"Significant improvement in heart rate variability — the body's measurable shift into deep rest."
A double-blinded randomised controlled trial of 54 university students compared vibroacoustic stimulation against a control group. The experimental group showed statistically significant improvement in heart rate variability (HRV) — a clinical marker of parasympathetic nervous system activation. In plain terms: their bodies measurably shifted into a deeper state of rest than lying down alone could achieve.
Read in Frontiers in Psychology →
BMJ Open · Scoping Review20 studies reviewed · 2022
"40 Hz was the most commonly used frequency, with sessions typically 20–45 minutes."
A comprehensive scoping review published in BMJ Open examined 20 studies on vibroacoustic therapy for adult pain — chronic, acute, and experimentally induced. The review found consistent evidence of benefit across multiple pain conditions and identified 40 Hz as the most commonly used therapeutic frequency, with sessions ranging from 20 to 45 minutes. The authors called for more controlled research but acknowledged established clinical application.
Read the BMJ Open review →
The honest part
Vibroacoustic therapy has real clinical research behind it — but it is still an emerging field. Most studies are small. The largest (NIH, 272 patients) was a program evaluation, not a double-blind RCT. The fibromyalgia study was open-label with 19 participants. We believe the evidence is strong enough to offer this responsibly, but we will not oversell it. This is not a cure. It is a tool — one that works best as part of a routine that includes sleep, movement, and proper nutrition. If you have a serious medical condition, please consult your doctor first.